Catalyst Wire Dossier Catalyst Wire Dossier

Trimeric glycoprotein gp140

gp140 · Crucell Holland BV
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trimeric glycoprotein gp140, covering 2016-06-06 to 2016-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers [Phase 1]

See pricing